Navigation Links
Misonix Reports First Quarter Fiscal Year 2009 Financial Results
Date:11/13/2008

Revenues Increased 7.4%; Net Income of $.05 per Diluted Share

FARMINGDALE, N.Y., Nov. 13 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today reported financial results for its fiscal year 2009 first quarter ended September 30, 2008. Michael A. McManus, Jr., President and Chief Executive Officer, and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Thursday, November 13, 2008 to discuss the Company's first quarter financial results.

-- Revenues increased 7.4% to $11.3 million

-- Reported net income of $320,000 or $.05 per diluted share

-- The Company reported the following operational achievements:

-- Entered a new, three year exclusive distribution agreement in Russia

for the Sonablate 500(R)

-- Received second FDA approval for the Sonablate 600(R) Soft Tissue

Ablation System

-- Entered a new two year exclusive distribution agreement in Czech

Republic for Sonastar(TM), SonicOne(R) and BoneScalpel(TM)

Revenues for the three months ended September 30, 2008 were $11.3 million, a 7.4% increase, when compared with revenues of $10.5 million for the same period in fiscal 2008. The increase is due to a $621,000 increase in sales of laboratory and scientific products to $5.9 million and a $154,000 increase in medical device products sales to $5.4 million. The increase in sales of medical device products is due to a $173,000 increase in therapeutic medical device products partially offset by a $1
'/>"/>

SOURCE Misonix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
2. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
3. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
4. Corgenix Reports Financial Results for First Quarter of Fiscal 2009
5. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
6. Spheris Reports Third Quarter 2008 Results
7. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
8. Symmetry Medical Reports Third Quarter 2008 Financial Results
9. EntreMed Reports Clinical Program Progress and Company Update
10. NBTY Reports Fourth Quarter and Fiscal Year Results
11. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014) Solid-head power toothbrushes retain less bacteria ... The University of Texas Health Science Center at ... the study are published in the August issue ... and professor at the UTHealth School of Dentistry, ... counts were lower in the solid-head toothbrush group ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 ISI ... management solutions, will be sponsoring the 2014 Presidio ... annual event allows Presidio leadership to engage with ... year. Specifically, they will be rolling out objectives ... , While at the event, ISI will be ...
(Date:8/28/2014)... A candidate Ebola vaccine could be given to healthy ... early as September, as part of an series of ... disease that has killed more than 1,400 people in ... of this candidate vaccine, being co-developed by the US ... be accelerated with funding from an international consortium in ...
(Date:8/28/2014)... prevent Ebola virus disease will begin next week by ... part of the National Institutes of Health. , The ... vaccine co-developed by NIAID and GlaxoSmithKline (GSK) and will ... an immune system response in healthy adults. Testing will ... Maryland. , The study is the first of several ...
(Date:8/28/2014)... People aged 70 and over who identify themselves as ... where they perceive they have lower value than younger ... University of Kent, titled ,Being old and ill, across ... subjective health, used data from the European Social Survey. ... asked to self-rate their health., The researchers found that ...
Breaking Medicine News(10 mins):Health News:UTHealth researchers find up to 3,000 times the bacterial growth on hollow-head toothbrushes 2Health News:ISI Telemanagement Solutions, Inc. to Sponsor 2014 Presidio Exchange 2Health News:Ebola vaccine trials fast-tracked by international consortium 2Health News:Ebola vaccine trials fast-tracked by international consortium 3Health News:Ebola vaccine trials fast-tracked by international consortium 4Health News:NIH to Launch human safety study of Ebola vaccine candidate 2Health News:NIH to Launch human safety study of Ebola vaccine candidate 3Health News:NIH to Launch human safety study of Ebola vaccine candidate 4Health News:NIH to Launch human safety study of Ebola vaccine candidate 5
... become one of the major public health problems in developed ... a researcher at the University of Zaragoza (UNIZAR), tells SINC. ... than two hours of television per day. At weekends, this ... July issue of the journal Preventive Medicine , show ...
... HealthDay Reporter , THURSDAY, Sept. 16 (HealthDay News) -- ... -- also known as cryotherapy -- works better than applying ... No one treatment cured more than half of cases, ... needed, experts say. The new finding is a bit ...
... Round Rock, Texas is recruiting patients for a Phase ... recurrence in previously treated patients. The trial will ... Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung ... Cell LunG Cancer Immunotherapy) study is expected to be ...
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. 16 ... risk of colorectal cancer, new research finds. Prior research ... colon cancer. But this study is among the first to ... side effects such as gastrointestinal bleeding -- may also be ...
... patients develop post-traumatic stress syndrome (PTSD) after the trauma ... to be exacerbated by delusional or fragmentary memories of ... writing in BioMed Central,s open access journal Critical ... relatives make a diary for patients, featuring information about ...
... significant and lasting relief for patients with myelofibrosis, a ... University of Texas MD Anderson Cancer Center report in ... . Myelofibrosis is caused by the accumulation of ... scarring the bone marrow and limiting its ability to ...
Cached Medicine News:Health News:Teenagers are more sedentary on weekends 2Health News:For Common Warts, Freezing Therapy Works Best: Study 2Health News:For Common Warts, Freezing Therapy Works Best: Study 3Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 2Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 3Health News:Intensive care diaries protect patients from PTSD 2Health News:JAK inhibitor provides rapid, durable relief for myelofibrosis patients 2Health News:JAK inhibitor provides rapid, durable relief for myelofibrosis patients 3
(Date:8/28/2014)... DENVER , Aug. 28, 2014 ... a two-year investment into this game-changing method for ... Today, clinical trials target specific cancers, ... be contributing factors for the cancer, in the ... is that this information may not be well ...
(Date:8/28/2014)... 28, 2014  In anticipation of the upcoming MEDevice ... available for the first time. Industry Overview: Medtech & ... offers a snapshot of San Diego,s ... from the latest employment statistics to current venture capital investment ... Diego such a vital part of the global ...
(Date:8/28/2014)... MINNEAPOLIS , Aug. 28, 2014 Nonin ... a leader in noninvasive medical monitoring, today announced that ... Nonin Model 3231 OEM/eHealth finger pulse oximeter for use ... finger pulse oximeter plugs into a telemedicine hub or ... and pulse rate in pediatric to adult patients. The ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Weiss, Director of Maryland Laser, Skin and Vein,Institute, ... BALTIMORE, Oct. 2 Robert Weiss, M.D., board ... U.S. to offer his,patients DOT Therapy (Dermal Optical ... Dr. Weiss is an,internationally renowned dermatologist, who is ...
... Biotechnologies AB and Dyax,Corp. (NASDAQ: DYAX ) ... a,collaboration to discover and to develop therapeutic ... inflammatory diseases., The collaboration follows the ... Professors Frostegard and de Faire of the ...
Cached Medicine Technology:DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 3Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 4
Curved shafts and tips with tying surfaces. Wide serrated handle with dull finish. Overall length 4.3 inches....
Straight heavy shafts with delicate 7 mm tying platform. Sharp pointed tips for removing fine sutures. Wide serrated handle with polished finish. Overall length 4.1 inches....
Angled 45 degree shafts with 10.5 mm tying and 1 mm of tip crisscross serrated. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.2 inches....
Curved, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Medicine Products: